There is now a wealth of evidence indicating that both constitutively and inductively expressed iNOS and its NO can reduce the efficacy of PDT against cancers and, in cases of incomplete tumor eradication, contribute to disease progression. This evidence concerns the gene NOS2 and neoplasm.